Earnings ·
Pediatrix reports Q3 EPS of $0.59 on $501M revenue, raises full-year Adjusted EBITDA outlook to $290-$300M
MDPediatrix Medical Group, Inc.
Pediatrix Medical Group reported third-quarter net income of $47 million, or $0.59 per diluted share, compared to $0.84 in the prior year period. Net revenue increased 1.7% to $501.4 million, driven by volume and pricing growth that outperformed expectations. Adjusted EBITDA came in at $85.5 million, slightly below the previous year's $87.3 million due to higher operating expenses offsetting revenue gains. The company also raised its full-year 2026 Adjusted EBITDA guidance to a range of $290 million to $300 million. Pediatrix Medical Group is a leading provider of physician services specializing in obstetrics, neonatology, and pediatric care.